cyclosporine has been researched along with Cancer of Skin in 175 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 46 (26.29) | 18.2507 |
| 2000's | 66 (37.71) | 29.6817 |
| 2010's | 56 (32.00) | 24.3611 |
| 2020's | 7 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enk, AH; Hadaschik, EN; Lonsdorf, AS; Menzer, C; Neuberger, A; Volk, N | 1 |
| Imai, H; Mitsui, A; Miyazaki, K; Nakajima, A; Noda, K; Sawaki, A; Shinoki, T; Suzuki, Y; Tawara, I; Yamamoto, Y | 1 |
| Ahn, J; Cho, YA; Choe, YB; Hong, JY; Kim, CY; Kim, SM; Lee, YW; Sung, JY; Won, S; Yu, DA | 1 |
| Cai, SCS; Lee, JSS; Tan, LS; Tee, SI | 1 |
| Arance, A; Ordás, I; Pesántez, D; Seguí, E; Viladot, M | 1 |
| Kemp, MG; Pugh, JM; Ume, AC; Williams, CR | 1 |
| Bagłaj, M; Giebel, S; Kamińska-Winciorek, G; Szlauer-Stefańska, A | 1 |
| Ascha, M; Ascha, MS; Bordeaux, JS; Tanenbaum, J | 1 |
| Campbell, S; Chadban, S; Kanellis, J; Lim, W; Masterson, R; O'Connell, P; Pilmore, H; Russ, G; Walker, R; Wong, G; Ying, T | 1 |
| Choi, J; Guitart, J; Kaplan, JB; Lee, DE; Martinez-Escala, ME; Pro, B; Serrano, LM; Zhou, XA | 1 |
| Abikhair Burgo, M; Carucci, JA; Chen, J; Doudican, N; Felsen, D; Proby, C; Roudiani, N; Santana, AL | 1 |
| Gutzmer, R; Satzger, I; Schaper-Gerhardt, K; Schmitz-Rode, C; Walter, A | 1 |
| Codarin, FR; Festa Neto, C; Oliveira, WRP; Silva, LLC; Souza, AAV; Tirico, MCCP | 1 |
| Bavinck, JN; Bodmann, CA; de Gruijl, FR; Geissler, EK; Koehl, GE; Tensen, CP; Voskamp, P; Willemze, R | 1 |
| Junco, JJ; Kim, DJ; Liang, H; Malik, G; Mancha, A; Slaga, TJ; Wei, SJ | 1 |
| Irvine, AD; McMenamin, M; O'Mahony, D; Wall, D | 1 |
| Gensure, RC | 1 |
| Djerbi, N; Dotto, GP; Dziunycz, PJ; Freiberger, SN; French, LE; Hofbauer, GFL; Iotzowa-Weiss, G; Lefort, K; Neu, J; Wu, X | 1 |
| Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB | 1 |
| Gota, V; Mehta, M; Patel, K; Patil, A; Vavia, P | 1 |
| Ryeom, S; Zhou, AY | 1 |
| Weiss, JM | 1 |
| Abdelmalek, M; Cusack, CA; Doyle, A; Henien, M; Malat, G; Miller, B; Nijhawan, R | 1 |
| Biernat, W; Dębska-Ślizień, A; Imko-Walczuk, B; Kryś, A; Lizakowski, S; Rutkowski, B; Wojnarowska, F | 1 |
| Akhavanpoor, M; Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Erbel, C; Frankenstein, L; Gleissner, CA; Helmschrott, M; Katus, HA; Klein, B; Rivinius, R; Ruhparwar, A; Schmack, B; Thomas, D | 1 |
| Clarke, CA; Engels, EA; Finch, JL; Fraumeni, JF; Hernandez, BY; Lynch, CF; Madeleine, MM; Pawlish, KS; Robbins, HA; Tatalovich, Z | 1 |
| Barraclough, KA; Burke, MT; Isbel, N; Jung, JW; Staatz, CE; Wells, JW | 1 |
| Campistol, JM; Canha, C; Castells, A; Diekmann, F; Ferreira, R; Moya-Rull, D; Oppenheimer, F; Revuelta, I; Rovira, J | 1 |
| Dotor, A; González-Herrada, C; Lapresta, A | 1 |
| Chen, CC; Teng, CL; Yeh, SP | 1 |
| Diem, S; Larkin, J; Spain, L | 1 |
| Dębska-Ślizień, A; Imko-Walczuk, B; Piesiaków, ML; Pikuła, M; Rutkowski, B; Trzonkowski, P | 1 |
| Abikhair, M; Bryan, T; Carucci, JA; Felsen, D; Gonzalez, J; Krueger, JG; Mitsui, H; Oberyszyn, TM; Ovits, C; Roudiani, N; Tober, KL; Yanofsky, V | 1 |
| Carucci, JA; Felsen, D; Santana, AL | 1 |
| Fernandez, A; Hu, S; Kirsner, RS | 1 |
| Clemares, M; Jiménez, C; Manrique, A; Marqués, E; Moreno, E; Ortega, P; Vallejo, GH | 1 |
| Danbara, M; Hayama, M; Higashihara, M; Horie, R; Ishii, R; Katayama, T; Miyazaki, K; Nakamura, N; Niitsu, N; Osaka, M; Suzuki, Y; Yoshida, T | 1 |
| Clark, LN; Lebwohl, M; Patel, RV; Weinberg, JM | 1 |
| Giese, T; Meuer, S; Sommerer, C; Zeier, M | 1 |
| Harwood, CA; Karran, P; McGregor, JM; Perrett, CM | 1 |
| Claudy, A; Decullier, E; Euvrard, S; Faure, M; Kanitakis, J; Rival-Tringali, AL | 1 |
| Boyd, S; Kyllönen, L; Latonen, L; Pärssinen, J; Saarialho-Kere, U; Skoog, T; Toftgard, R; van Hogerlinden, M; Virolainen, S | 1 |
| Oberyszyn, TM; Schick, JS; Thomas-Ahner, JM; Wulff, BC | 1 |
| Adami, J; Bellocco, R; Fernberg, P; Höglund, P; Ingvar, A; Lindelöf, B; Smedby, KE; Tufveson, G | 1 |
| Canter, JA; Milne, GL; Morrow, JD; Norman, KG; Shi, M; Sligh, JE | 1 |
| Eagle, RC; Edward, DP; Fontanilla, FA; Goldstein, DA; Tessler, HH; Wong, M | 1 |
| Chang, HH; Chen, IM; Chen, PL; Hsieh, YC; Lai, ST; Shih, CC; Weng, ZC; Yang, AH | 1 |
| Akyazi, H; Alpay, K; Bahadir, S; Cobanoğlu, U; Yayli, S | 1 |
| Han, W; He, TC; He, YY; Ming, M | 1 |
| Fujisawa, T; Seishima, M | 1 |
| Bennett, DD; Busick, TL; Cohen, JB | 1 |
| Campbell, LS; Geskin, LJ; Jukic, DM; Pomerantz, RG | 1 |
| Brooks, Y; Chang, S; Dotto, GP; Dziunycz, P; Hofbauer, GF; Lefort, K; Nguyen, BC; Wu, X | 1 |
| Forner, MJ; Jordá, E; López, V; Martín, JM; Molina, I; Santonja, N | 1 |
| Di Lernia, V; Ricci, C | 1 |
| Brocard, A; Dréno, B; Knol, AC; Peuvrel, L; Quéreux, G; Renaut, JJ | 1 |
| Celik, S; Dengler, TJ; Doesch, AO; Ehlermann, P; Frankenstein, L; Katus, HA; Konstandin, M; Kristen, A; Müller, S; Sack, FU | 1 |
| Martin, L | 1 |
| Athar, M; Elmets, CA; Grizzle, WE; Huang, CC; Kopelovich, L; Kurundkar, AR; Maheshwari, A; Timares, L; Walsh, SB; Xu, H; Xu, J | 1 |
| Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S | 1 |
| Barańska-Rybak, W; Cegielska, A; Gniadecki, R; Lugowska-Umer, H; Sokołowska-Wojdyło, M; Trzeciak, M | 1 |
| Apel, A; Boeckmann, L; Emmert, S; Kuschal, C; Laspe, P; Schön, MP; Thoms, KM | 1 |
| Koo, JY; Muellenhoff, MW | 1 |
| Anemona, L; Chimenti, S; Di Stefani, A; Saggini, A; Saraceno, R | 1 |
| Bachelez, H; Paul, C | 1 |
| Arcese, A; Camplone, G; Carlesimo, M; Di Russo, PP; Gamba, A; La Pietra, M; Mari, E; Orsini, D | 1 |
| Berger, W; Bilban, M; Bracher, A; Heinz, M; Knöfler, M; Loewe, R; Niederleithner, H; Pehamberger, H; Petzelbauer, P; Sonderegger, S; Tauber, S | 1 |
| Anichini, A; Baldassari, P; Bersani, I; Dal Col, J; Dolcetti, R; Molla, A; Mortarini, R; Perotti, V; Tassi, E; Vegetti, C | 1 |
| Afaq, F; Arumugam, A; Athar, M; Elmets, CA; Walsh, SB; Xu, J | 1 |
| Brocard, A; Broeders, N; Campistol, JM; Chatelet, V; Dantal, J; Decullier, E; del Marmol, V; Dompmartin, A; Euvrard, S; Goffin, E; Hofbauer, GF; Kanitakis, J; Kessler, M; Morelon, E; Pouteil-Noble, C; Rostaing, L; Roux, AS; Serra, AL; Tromme, I | 1 |
| Han, W; He, YY; Ming, M; Soltani, K | 1 |
| Bailey, D; Balkman, C; Beaulieu, BB; Flory, A; Kiselow, M; Lewis, LD; McEntee, M; Waite, A | 1 |
| Bertoni, E; Caroti, L; Carta, P; Larti, A; Moscarelli, L; Paudice, N; Pimpinelli, N; Salvadori, M; Tsalouchos, A; Zanazzi, M | 1 |
| Blewitt, RW; Kirby, B; Owen, CM; Yates, VM | 1 |
| García-Suárez, J; Krsnik, I; López-Rubio, M; Santana, A | 1 |
| Gordon, KB; McClure, SL; Valentine, J | 1 |
| Christophers, E; Dubertret, L; Guillaume, JC; Ho, VC; Lamarque, V; McGeown, C; Paul, CF; Schmidtmann, B | 1 |
| Agnew, KL; Bunker, CB | 1 |
| Altieri, E; Corazza, M; Montanari, A; Virgili, A; Zampino, MR | 1 |
| Crickx, B; Descamps, V; Fraitag, S; Grossin, M; Mahé, E | 1 |
| Huang, FS; Lucky, AW; Murphy, S; Paller, AS; Passo, M; Prendiville, J; Shani-Adir, A | 1 |
| Beani, JC | 1 |
| Andrassy, J; Geissler, EK; Graeb, C; Guba, M; Jauch, KW; Koehl, GE; Kroemer, A; Richter, S; Scherer, MN; Schlitt, HJ; Steinbauer, M | 1 |
| Friend, P; Kreis, H; Mathew, T | 1 |
| Jin, SY; Kim, HK; Lee, NS; Park, HS; Won, JH; Yang, WI | 1 |
| Campana, C; Cavallini, D; Incardona, P; Ippoliti, G; Lucioni, M; Magrini, U; Paulli, M; Riboni, R; Viganò, M; Viglio, A | 1 |
| Christensen, ND; Cladel, NM; Hu, J; Peng, X; Pickel, MD | 1 |
| Epstein, EH; Hebert, J; Hwang, J; Lu, Y; Vogt, A | 1 |
| Almaraz, A; Blanco, G; Fernández, N; López-Velasco, R; Morilla-Grasa, A; Ordóñez, JL; Rábano, G; Saornil-Alvarez, MA | 1 |
| Maragh, SL; Otley, CC | 1 |
| Feun, L; Hurley, J; Marini, A; Mazumder, A; Moffat, F; Savaraj, N | 1 |
| Callan, MB; Mauldin, E; Preziosi, D | 1 |
| Buell, JF; Gross, TG; Woodle, ES | 1 |
| Brown, DA; Canning, MT; Nay, SL; Pena, AV; Yarosh, DB | 1 |
| Gralla, J; Moosa, MR | 1 |
| Haustein, UF; Paasch, U | 1 |
| Brzosko, M; Flicinski, J; Olewniczak, S | 1 |
| Kolhe, N; Mamode, N; Pattison, J; Van der Walt, J | 1 |
| Fernández, AM; Marcén, R; Ortuño, J; Pascual, J | 1 |
| Balme, B; Dalle, S; Houot, R; Mougel, F; Thomas, L | 1 |
| Scheinfeld, N | 1 |
| Demir, M; Kundak, T; Pamuk, GE; Turgut, B; Vural, O | 1 |
| Assanasen, T; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P; Wannakrairot, P | 1 |
| Ahmed, H; Ahmed, J; Budruddin, M; Campistol, JM; Daar, A; Jha, A; Kamble, P; Khalil, M; Mohammed, E; Mohsin, N; Pakkyarra, A; Thomas, S | 1 |
| Allen, SD; Duncan, FJ; Ferketich, AK; Kusewitt, DF; Martin, J; Oberyszyn, TM; Thomas-Ahner, JM; Tober, KL; Vanbuskirk, AM; Wulff, BC | 1 |
| Járay, J; Végso, G | 1 |
| Pukkala, E; Ranki, A; Reitamo, S; Sarna, S; Väkevä, L | 1 |
| Gu, X; Liu, J; St Clair, DK; Zhao, Y | 1 |
| Aubert, JD; Duchosal, MA; Laffitte, E; Panizzon, RG; Pascual, M; Venetz, JP | 1 |
| Duncan, FJ; Kusewitt, DF; Oberyszyn, TM; Thomas-Ahner, JM; VanBuskirk, AM; Wulff, BC | 1 |
| Iijima, M; Oguro, T; Sueki, H; Yajima, Y; Yoshida, T | 1 |
| Kautzky, F; Köhler, LD; Vogt, HJ | 1 |
| Davison, AM; Farmery, SM; Lodge, JP; London, NJ; Will, EJ | 1 |
| Bellamy, J; Benoit, G; Blanchet, P; Charpentier, B; Hiesse, C; Kriaa, F; Larue, JR | 1 |
| Claudy, A; Disant, F; Dureau, G; Euvrard, S; Finaz de Villaine, J; Kanitakis, J; Pouteil-Noble, C; Thivolet, J | 1 |
| Abouna, GM; Kumar, MS; Samhan, M | 1 |
| Lipkowitz, GS; Madden, RL | 1 |
| Bellamy, J; Benoit, G; Blanchet, P; Charpentier, B; Hiesse, C; Kriaa, F; Larue, JR; Rieu, P | 1 |
| Bergfelt, L | 1 |
| Bergfelt, L; Blohmé, I; Larkö, O | 1 |
| Dunn, DL; Gillingham, K; Gruber, SA; Matas, AJ; Sothern, RB; Stephanian, E | 1 |
| Bulengo-Ransby, SM; Maize, JC; Metcalf, JS; Sahn, EE | 1 |
| Bencini, PL; Caputo, R; Montagnino, G; Ponticelli, C; Tarantino, A | 1 |
| Chavers, B; Dunn, DL; Gillingham, K; Gruber, SA; Matas, AJ; Sothern, RB; Stephanian, E | 1 |
| Seddon, SV; Shepherd, JP; Thomas, DW | 1 |
| Barry, JM; Batiuk, TD; Bennett, WM; Meyer, MM; Norman, DJ; Tolzman, D | 1 |
| Alessi, E; Bencini, PL; Caputo, R; Montagnino, G; Ponticelli, C; Tarantino, A | 1 |
| Green, C; Hawk, JL | 1 |
| Amiss, N; Disney, AP; Mathew, TH; Sheil, AG | 1 |
| Caro, WA; Malkinson, FD; Pakula, A; Valicenti, JM | 1 |
| Penn, I | 1 |
| Bakkaloglu, A; Besbas, N; Buyukpamukcu, M; Gokoz, A; Karaduman, A; Ozen, S; Saatci, U | 1 |
| Burra, P; Di Landro, D; Galligioni, A; Graziotto, A; Halmos, O; Inturri, P; Poletti, A; Rigotti, P; Rossaro, L; Tedeschi, U | 1 |
| Bergmann, BM; Gilliland, MA; Quintans, J; Rechtschaffen, A | 1 |
| Czyz, W; Sobczak-Radwan, K; Szepietowski, J; Szepietowski, T; Wasik, F; Włodarczyk, M | 1 |
| Cunningham, J; Deeks, JJ; Glover, MT; Leigh, IM; Raftery, MJ | 1 |
| de Rooij, MJ; van de Kerkhof, PC | 1 |
| Cerimele, D; Diociaiuti, A; Lesnoni La Parola, I; Masini, C; Nanni, G; Panocchia, N | 1 |
| Boneschi, V; Brambilla, L; Ferrucci, S; Finzi, AF; Fossati, S | 1 |
| Burg, G; Dummer, R; Kempf, W; Waldmann, V | 1 |
| Aebischer, MC; Braathen, LR; Zala, LB | 1 |
| Bechstein, WO; Guckelberger, O; Jonas, S; Neuhaus, P; Neuhaus, R; Neumann, U; Rayes, N; Serke, S; Tullius, SG | 1 |
| Bakr, MA; el-Agroudy, A; el-Baz, M; el-Mekresh, M; Fouda, MA; Ghoneim, MA; Moustafa, F; Sally, S; Sobh, M; Wafa, E | 1 |
| Bunker, CB; Gooptu, C; Morris, PJ; Price, M; Ross, J; Wall, S; Wojnarowska, F; Woollons, A | 1 |
| Barba, A; Chieregato, GC; Talamini, G; Tessari, G | 1 |
| Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML | 1 |
| Qunibi, W; Sabeel, A | 1 |
| Veness, MJ | 1 |
| Brennan, DC; Humphrey, PA; Jones, TR | 1 |
| De Felipe, I; Redondo, P | 1 |
| Boehringer, M; Keller, F; Schwarz, A | 1 |
| Darius, H; Ibe, W; Meyer, J; Sebastian, M; Wittlinger, T | 1 |
| Dong, H; Hirpara, JL; Kini, RM; Loh, KW; Pervaiz, S; Seyed, MA | 1 |
| Otley, CC; Pittelkow, MR | 1 |
| Dobozy, A; Gyulai, R; Kemeny, L; Nagy, S; Szenohradszky, P | 1 |
| Hussein, MM; Mooij, JM; Roujouleh, HM | 1 |
| Alaibac, M; Caforio, AL; Casarotto, D; Feltrin, G; Fortina, AB; Gambino, A; Peserico, A; Piaserico, S; Pompei, E; Testolin, L; Thiene, G; Tona, F; Volta, SD | 1 |
| Gulliver, WP | 1 |
| Fauchald, P; Geiran, O; Gjersvik, P; Hansen, S; Leivestad, T; Møller, B; Pfeffer, P; Simonsen, S | 1 |
| Hail, N; Lotan, R | 1 |
| Kasper, RC; LeBoit, PE; Nihal, M; Wood, GS | 1 |
| Osborn, FD; Sebelik, ME; Snowden, RT; Wong, FS | 1 |
| Einollahi, B; Khatami, MR; Lessan-Pezeshki, M; Mahdavi, M | 1 |
| Marcil, I; Stern, RS | 1 |
| Anjum, R; Joshi, P; Khar, A | 1 |
| Duvic, M; Frazier, OH; Jackow, CM; McMullan, DM; Radovaneević, B | 1 |
| Duvic, M; Jones, D; Pielop, JA | 1 |
| Amenábar, JJ; Gaínza, FJ; Gómez-Ullate, P; Lampreabe, I; Urbizu, JM; Zárraga, S | 1 |
| Bowman, PH; Jones, C; Kashani-Sabet, M; Koo, J; LeBoit, PE; McCalmont, TH; Zackheim, HS; Zehnder, J | 1 |
| Amir, G; Friedlaender, MM; Rosenbaum, E; Rubinger, D; Siguencia, E | 1 |
| Cameron, EC; Chui, A; Karim, M; Keown, PA; Landsberg, D; McBride, M; Melosky, B; Shackleton, C; Yeung, CK | 1 |
| Cantarell, MC; Castelao, AM; Lauzurica, R; Oppenheimer, F; Puig, JM; Solá, R; Vilardell, J | 1 |
| Blohmé, I; Larkö, O | 1 |
| Eigler, FW | 1 |
| Garden, J; Pakula, A | 1 |
25 review(s) available for cyclosporine and Cancer of Skin
| Article | Year |
|---|---|
Calcineurin inhibitor (CNI)-associated skin cancers: New insights on exploring mechanisms by which CNIs downregulate DNA repair machinery.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; DNA Damage; DNA Repair; Humans; Protein Isoforms; Skin Neoplasms; Tacrolimus; Ultraviolet Rays | 2020 |
Secondary skin neoplasms in patients after autologous and allogeneic hematopoietic stem cell transplantation procedures.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Skin Neoplasms; Transplantation, Homologous | 2020 |
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha | 2014 |
Genetics and nonmelanoma skin cancer in kidney transplant recipients.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Pharmacogenetics; Prednisolone; Prednisone; Skin Neoplasms; Tacrolimus | 2015 |
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
Management of toxicities of immune checkpoint inhibitors.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Colitis; CTLA-4 Antigen; Cyclosporine; Diarrhea; Drug Eruptions; Humans; Immunosuppressive Agents; Infliximab; Ipilimumab; Kidney Neoplasms; Lung Neoplasms; Melanoma; Mycophenolic Acid; Neoplasms; Nivolumab; Pituitary Diseases; Programmed Cell Death 1 Receptor; Skin Neoplasms; Tacrolimus; Thyroiditis | 2016 |
Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Proliferation; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-22; Interleukins; Skin Neoplasms; Transplant Recipients; Tumor Microenvironment | 2017 |
Lymphoproliferative disorders after immunosuppressive therapy for aplastic anemia: a case report and literature review.
Topics: Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Japan; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Radionuclide Imaging; Radiotherapy; Rituximab; Skin Neoplasms; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed; Vincristine | 2009 |
Treatments for psoriasis and the risk of malignancy.
Topics: Biological Products; Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Mycophenolic Acid; Psoriasis; PUVA Therapy; Skin Neoplasms; Ultraviolet Therapy | 2009 |
Carcinogenic mechanisms related to immunosuppressive therapy.
Topics: Azathioprine; Carcinogens; Cyclosporine; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Models, Biological; Organ Transplantation; Signal Transduction; Skin Neoplasms | 2009 |
[What's new in dermatological treatments?].
Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab | 2010 |
Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Randomized Controlled Trials as Topic; Risk Factors; Skin; Skin Neoplasms | 2012 |
Comparative tolerability of systemic treatments for plaque-type psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms | 2002 |
CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.
Topics: Antibodies, Monoclonal; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Psoriasis; Skin Neoplasms | 2003 |
Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Diagnosis, Differential; Extremities; Face; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Panniculitis; Skin Neoplasms | 2004 |
[Prescription of phototherapy in psoriasis].
Topics: Acute Disease; Combined Modality Therapy; Cyclosporine; Furocoumarins; Humans; Immunosuppressive Agents; Photosensitizing Agents; Phototherapy; Psoriasis; Risk Factors; Severity of Illness Index; Skin Neoplasms | 2004 |
Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy.
Topics: Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Organ Transplantation; Prednisolone; Randomized Controlled Trials as Topic; Skin Neoplasms | 2005 |
Malignancy after transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Neoplasms; Sirolimus; Skin Neoplasms; Tacrolimus; Transplantation Immunology; Transplantation, Homologous | 2005 |
A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
Topics: Animals; Antineoplastic Agents; Benzoates; Boronic Acids; Bortezomib; Cyclosporine; Dasatinib; Deferasirox; Humans; Iron Chelating Agents; Ophthalmic Solutions; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; Thiazoles; Triazoles | 2007 |
[Malignant tumors following renal transplantation].
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Muromonab-CD3; Neoplasms; Prognosis; Sarcoma, Kaposi; Skin Neoplasms; Tacrolimus | 2007 |
Skin cancer in liver transplant recipients.
Topics: Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis; Liver Transplantation; Postoperative Complications; Skin Neoplasms; Tacrolimus | 2000 |
Superficial leiomyosarcoma of the head and neck: case report and review of the literature.
Topics: Cyclosporine; Diagnosis, Differential; Fatal Outcome; Head and Neck Neoplasms; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Skin; Skin Neoplasms; Tomography, X-Ray Computed | 2001 |
Cutaneous T-cell lymphoma in a cardiac transplant recipient.
Topics: Aged; Azathioprine; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mycosis Fungoides; Photopheresis; Prednisone; PUVA Therapy; Sezary Syndrome; Skin Neoplasms | 2001 |
[Presentation of cancers in recipients of a solid-organ transplant].
Topics: Carcinogens; Cell Transformation, Neoplastic; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Melanoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Postoperative Complications; Prevalence; Recurrence; Risk; Sarcoma, Kaposi; Skin Neoplasms; Transplantation; Tumor Virus Infections; Ultraviolet Rays | 2001 |
Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression.
Topics: Actuarial Analysis; Antilymphocyte Serum; Azathioprine; Carcinoma; Cyclosporine; Graft Survival; Herpesviridae Infections; Humans; Immunosuppression Therapy; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Lymphoproliferative Disorders; Muromonab-CD3; Postoperative Complications; Prednisone; Prevalence; Registries; Retrospective Studies; Risk; Skin Neoplasms; Tumor Virus Infections | 1992 |
9 trial(s) available for cyclosporine and Cancer of Skin
| Article | Year |
|---|---|
De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study.
Topics: Australia; Cyclosporine; Everolimus; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prognosis; Risk Factors; Sirolimus; Skin Neoplasms; Transplant Recipients | 2018 |
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
Topics: Adult; Aged; Aged, 80 and over; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cyclosporine; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sirolimus; Skin Neoplasms; Tacrolimus | 2012 |
Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cyclosporine; Dermatologic Agents; Docetaxel; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Male; Skin Neoplasms; Taxoids | 2014 |
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
Topics: Adult; Cyclosporine; Dermatologic Agents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prospective Studies; Psoriasis; PUVA Therapy; Risk Factors; Skin Neoplasms | 2003 |
Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclosporine; Dacarbazine; Female; Humans; Immunosuppressive Agents; Interferon-alpha; Interleukin-2; Male; Melanoma; Skin Neoplasms; Tamoxifen; Treatment Outcome | 2005 |
Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.
Topics: Adenoma, Bile Duct; Age Factors; Azathioprine; Cyclosporine; Follow-Up Studies; Humans; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoma; Male; Muromonab-CD3; Neoplasms; Prostatic Neoplasms; Retrospective Studies; Skin Neoplasms; Thyroid Neoplasms | 1993 |
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Clinical Trials as Topic; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoma; Neoplasms, Second Primary; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Interleukin-2; Skin Neoplasms; Tacrolimus; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1997 |
Analysis of risk factors for cutaneous warts in renal transplant recipients.
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Body Mass Index; Cyclosporine; Female; Follow-Up Studies; HLA-A Antigens; HLA-B Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisolone; Risk Factors; Skin Neoplasms; Warts | 1997 |
No difference in skin cancer incidence with or without cyclosporine--a 5-year perspective.
Topics: Azathioprine; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Follow-Up Studies; Humans; Incidence; Keratoacanthoma; Kidney Transplantation; Prednisolone; Skin Neoplasms | 1992 |
141 other study(ies) available for cyclosporine and Cancer of Skin
| Article | Year |
|---|---|
Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Topics: Aged; Aged, 80 and over; Apoptosis Regulatory Proteins; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Female; Gene Expression Regulation, Neoplastic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Proto-Oncogene Proteins; Risk Factors; Skin Neoplasms; Ultraviolet Rays; Up-Regulation | 2021 |
Subcutaneous Panniculitis-like T-cell Lymphoma with a HAVCR2 Mutation Diagnosed after 10 Years of Treatment with Glucocorticoids and Cyclosporine as Lupus Panniculitis.
Topics: Adult; Cyclosporine; Diagnosis, Differential; Glucocorticoids; Hepatitis A Virus Cellular Receptor 2; Humans; Lymphoma, T-Cell; Male; Mutation; Neoplasm Recurrence, Local; Panniculitis; Panniculitis, Lupus Erythematosus; Skin Neoplasms | 2023 |
Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study.
Topics: Cohort Studies; Cyclosporine; Humans; Psoriasis; Republic of Korea; Skin Neoplasms | 2022 |
Fibroblastic Rheumatism Versus Variant Disease of Multinucleate Cell Angiohistiocytoma.
Topics: Antirheumatic Agents; Cyclosporine; Diagnosis, Differential; Female; Fibroblasts; Giant Cells; Hemangioma; Histiocytoma; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Rheumatic Diseases; Skin Diseases; Skin Neoplasms | 2020 |
Successful management of refractory immune-mediated enterocolitis with cyclosporine.
Topics: Adult; Antineoplastic Agents, Immunological; Biopsy; Colon; Colonoscopy; Cyclosporine; Drug Resistance; Enterocolitis; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Melanoma; Methylprednisolone; Programmed Cell Death 1 Receptor; Skin Neoplasms; Treatment Outcome | 2020 |
Risk Factors for Melanoma in Renal Transplant Recipients.
Topics: Adult; Age Factors; Aged; Cohort Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Male; Melanoma; Middle Aged; Registries; Risk Factors; Sirolimus; Skin Neoplasms; Time Factors; Tissue Donors; Transplant Recipients; United States | 2017 |
Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Skin Neoplasms | 2018 |
Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Interleukin-22; Interleukins; Janus Kinase 1; Mice; Mice, Nude; Nitriles; Organ Transplantation; Pyrazoles; Pyrimidines; Receptors, Interleukin; Signal Transduction; Skin Neoplasms; STAT1 Transcription Factor; STAT3 Transcription Factor | 2018 |
The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes.
Topics: Activating Transcription Factor 3; Calcineurin Inhibitors; Carcinogenesis; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cyclosporine; Down-Regulation; Humans; Immunosuppressive Agents; Keratinocytes; Oncogenes; Organ Transplantation; Sirolimus; Skin; Skin Neoplasms; TOR Serine-Threonine Kinases; Ultraviolet Rays | 2018 |
Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
Topics: Adolescent; Adult; Aged; Azathioprine; Brazil; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child; Cyclosporine; Dermatomycoses; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Organ Transplantation; Risk Factors; Skin Diseases, Infectious; Skin Neoplasms; Tacrolimus; Warts; Young Adult | 2019 |
No acceleration of UV-induced skin carcinogenesis from evenly spread dietary intake of cyclosporine in contrast to oral bolus dosages.
Topics: Administration, Oral; Animals; Carcinogenesis; Cyclosporine; Dose-Response Relationship, Drug; Immunosuppressive Agents; Mice; Mice, Hairless; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Skin Neoplasms; Ultraviolet Rays | 2013 |
Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Survival; Cyclosporine; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Mice; Resveratrol; Rhodamine 123; Skin Neoplasms; Stilbenes; Triterpenes; Ursolic Acid; Verapamil | 2013 |
Kaposi sarcoma in an patient with atopic dermatitis treated with ciclosporin.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Leg; Male; Sarcoma, Kaposi; Skin; Skin Neoplasms | 2013 |
Clinical response to combined therapy of cyclosporine and prednisone.
Topics: Adolescent; Alopecia Areata; Anti-Inflammatory Agents; Cyclosporine; Down Syndrome; Drug Therapy, Combination; Female; Hashimoto Disease; Humans; Immunosuppressive Agents; Papilloma; Prednisone; Primary Ovarian Insufficiency; Skin Neoplasms | 2013 |
The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A.
Topics: Activating Transcription Factor 3; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratinocytes; Neoplasms, Radiation-Induced; NF-E2-Related Factor 2; Organ Culture Techniques; Organ Transplantation; Primary Cell Culture; Reactive Oxygen Species; Skin; Skin Neoplasms; Tumor Cells, Cultured; Ultraviolet Rays | 2014 |
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Clarithromycin; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Compounding; Gastrointestinal Tract; Hypromellose Derivatives; Ileum; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Skin Neoplasms; Surface Properties; Tumor Burden | 2014 |
Cyclosporin A promotes tumor angiogenesis in a calcineurin-independent manner by increasing mitochondrial reactive oxygen species.
Topics: Animals; Antioxidants; Calcineurin; Cell Movement; Cell Proliferation; Cyclosporine; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mice, Inbred C57BL; Mitochondria; Neovascularization, Pathologic; Reactive Oxygen Species; Skin Neoplasms | 2014 |
[Journal-Club].
Topics: Activating Transcription Factor 3; Animals; Carcinoma, Squamous Cell; Cyclosporine; Female; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 6; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-23; Keratinocytes; Male; Neoplasms, Radiation-Induced; Nociceptors; Papillomavirus E7 Proteins; Papillomavirus Infections; Psoriasis; Sensory Receptor Cells; Skin; Skin Neoplasms; Ultraviolet Rays | 2014 |
Vismodegib for locally advanced basal cell carcinoma in a heart transplant patient.
Topics: Aged; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Cyclosporine; Drug Monitoring; Facial Neoplasms; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Pyridines; Skin Neoplasms | 2015 |
Sebaceous carcinoma in patients receiving long-term immunosuppresive treatment: case report and literature review.
Topics: Aged, 80 and over; Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Fatal Outcome; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasms, Multiple Primary; Sebaceous Gland Neoplasms; Skin Neoplasms | 2014 |
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Melanoma; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasms; Risk Factors; Skin Neoplasms; Survival Analysis; Tacrolimus | 2015 |
Risk of merkel cell carcinoma after solid organ transplantation.
Topics: Adult; Aged; Azathioprine; Carcinoma, Merkel Cell; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Male; Middle Aged; Organ Transplantation; Photosensitizing Agents; Poisson Distribution; Registries; Remission Induction; Risk Assessment; Risk Factors; Skin Neoplasms; TOR Serine-Threonine Kinases; Transplant Recipients; Ultraviolet Rays; United States | 2015 |
A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
Topics: Adenocarcinoma; Aged; Azathioprine; Biomarkers; Cyclosporine; Drug Substitution; Esophageal Neoplasms; Esophagectomy; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasm Proteins; Neoplasms, Second Primary; Phosphorylation; Postoperative Complications; Prednisone; Protein Processing, Post-Translational; Sarcoma, Kaposi; Signal Transduction; Sirolimus; Skin Neoplasms; TOR Serine-Threonine Kinases | 2015 |
Toxic epidermal necrolysis induced by vemurafenib.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Drug Substitution; Humans; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Stevens-Johnson Syndrome; Sulfonamides; Vemurafenib | 2015 |
Associations of Selected Cytokines Levels in Organ Transplant Recipients Without and With Malignant Skin Neoplasms.
Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Cytokines; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-2; Male; Middle Aged; Mycophenolic Acid; Organ Transplantation; Postoperative Complications; Skin Neoplasms; Transforming Growth Factor beta | 2016 |
Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-22; Interleukins; Mice; Receptors, Interleukin; Skin Neoplasms | 2016 |
Sirolimus: a potential chemopreventive agent.
Topics: Animals; Antineoplastic Agents; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mice; Organ Transplantation; Sirolimus; Skin Neoplasms; Ultraviolet Therapy | 2008 |
Development of lymphoproliferative disease after liver transplantation.
Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Transplantation; Lymphoproliferative Disorders; Male; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Analysis; Survivors; Tacrolimus | 2008 |
Monitoring immunosuppression with measures of NFAT decreases cancer incidence.
Topics: Aged; Cyclosporine; Cytokines; Drug Monitoring; Gene Expression; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphocytes; Male; Monitoring, Immunologic; NFATC Transcription Factors; Skin Neoplasms | 2009 |
Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.
Topics: Adult; Aged; Angiogenesis Inhibitors; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cohort Studies; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neovascularization, Pathologic; Postoperative Complications; Sirolimus; Skin Neoplasms; Treatment Outcome | 2009 |
MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer.
Topics: Aged; Aged, 80 and over; Animals; Bowen's Disease; Cyclosporine; Disease Models, Animal; Endothelium; ErbB Receptors; Female; Fibroblasts; Humans; Immunosuppression Therapy; Keratinocytes; Kidney Transplantation; Lymphocytes; Macrophages; Male; Matrix Metalloproteinase 10; Matrix Metalloproteinase 12; Matrix Metalloproteinases, Secreted; Mice; Mice, Transgenic; Middle Aged; Neoplasms, Squamous Cell; Neutrophils; Skin; Skin Neoplasms; Stromal Cells | 2009 |
Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.
Topics: Animals; Blotting, Western; Caspase 3; Celecoxib; Cyclooxygenase Inhibitors; Cyclosporine; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Female; Immunohistochemistry; Immunosuppressive Agents; Mice; Neoplasms, Radiation-Induced; Pyrazoles; Sirolimus; Skin Neoplasms; Sulfonamides; Tumor Suppressor Protein p53; Ultraviolet Rays | 2010 |
Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Azathioprine; Carcinoma, Squamous Cell; Case-Control Studies; Child; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Male; Middle Aged; Risk Factors; Skin Neoplasms; Sweden; Time Factors; Young Adult | 2010 |
Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients.
Topics: Cell Death; Cell Line; Cell Survival; Cyclosporine; Humans; Immunosuppressive Agents; Keratinocytes; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Organ Transplantation; Skin Neoplasms; Ultraviolet Rays | 2010 |
Juvenile xanthogranuloma masquerading as melanoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Child; Chlorambucil; Cyclosporine; Diagnosis, Differential; Drug Resistance; Humans; Immunosuppressive Agents; Male; Melanoma; Prednisone; Skin Neoplasms; Visual Acuity; Xanthogranuloma, Juvenile | 2009 |
Malignancy after heart transplantation.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Heart Transplantation; Humans; Incidence; Lymphoproliferative Disorders; Middle Aged; Neoplasms; Risk Factors; Skin Neoplasms | 2009 |
Coexistence of basal cell carcinomas and multiple sebaceous gland hyperplasias in a cyclosporine (ciclosporin)-treated renal transplant recipient.
Topics: Carcinoma, Basal Cell; Cyclosporine; Face; Humans; Hyperplasia; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nose; Sebaceous Gland Diseases; Skin Neoplasms; Treatment Outcome | 2010 |
Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclosporine; Enzyme Activation; HeLa Cells; Humans; Immunosuppressive Agents; Keratinocytes; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Skin Neoplasms | 2010 |
Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome.
Topics: Adult; Cyclosporine; Glucocorticoids; Histiocytoma, Malignant Fibrous; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Prednisone; Sjogren's Syndrome; Skin Neoplasms | 2010 |
Pyoderma gangrenosum responding to ciclosporin without adverse effects in a patient with lymphomatoid papulosis.
Topics: Clobetasol; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphomatoid Papulosis; Middle Aged; Pyoderma Gangrenosum; Skin Neoplasms | 2010 |
Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, T-Cell, Cutaneous; Male; Risk Factors; Sex Factors; Skin Neoplasms; Tacrolimus | 2010 |
Opposing roles for calcineurin and ATF3 in squamous skin cancer.
Topics: Activating Transcription Factor 3; Animals; Calcineurin; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cellular Senescence; Cyclosporine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Keratinocytes; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; NFATC Transcription Factors; Signal Transduction; Skin Neoplasms; Tumor Suppressor Protein p53 | 2010 |
Eruptive nevi in a patient receiving cyclosporine A for psoriasis treatment.
Topics: Adult; Cyclosporine; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Nevus; Psoriasis; Skin Neoplasms | 2010 |
Cutaneous malignancies during treatment with efalizumab and infliximab: When temporal relationship does not mean causality.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Cyclosporine; Dermatologic Agents; Female; Humans; Infliximab; Psoriasis; PUVA Therapy; Skin Neoplasms; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
Topics: Adult; Antibiotics, Antineoplastic; Biopsy; Cyclosporine; Doxorubicin; Etanercept; Fatal Outcome; Humans; Immunoglobulin G; Immunosuppressive Agents; Leg; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Neoplasms; Treatment Failure | 2010 |
Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
Topics: Adolescent; Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Germany; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Skin Neoplasms; Survival Rate; Time Factors; TOR Serine-Threonine Kinases; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGFβ signaling pathway.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cyclosporine; Epithelial-Mesenchymal Transition; Female; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Skin Neoplasms; Transforming Growth Factor beta; Transplantation, Heterologous | 2011 |
Cutaneous fusariosis developing in a post-irradiation site.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclosporine; Dermatitis, Atopic; Diagnostic Errors; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Precancerous Conditions; Predictive Value of Tests; Sezary Syndrome; Skin; Skin Neoplasms; Treatment Outcome | 2011 |
Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
Topics: Calcineurin; Calcineurin Inhibitors; Cell Line; Cyclosporine; DNA Repair; DNA-Binding Proteins; Down-Regulation; Endonucleases; Fibroblasts; Humans; Immunosuppressive Agents; Nuclear Proteins; RNA Interference; RNA, Messenger; Skin Neoplasms; Transcription Factors; Transplants; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein | 2011 |
Mycosis fungoides in the setting of T-cell large granular lymphocyte proliferative disorder.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Ultraviolet Therapy | 2012 |
[Choice of therapy based on clinical setting].
Topics: Age Factors; Comorbidity; Contraindications; Cyclosporine; Decision Making; Dermatologic Agents; Female; Hepatic Insufficiency; Humans; Kidney Diseases; Latent Tuberculosis; Mental Disorders; Methotrexate; Pregnancy; Psoriasis; Risk Factors; Skin Neoplasms | 2011 |
Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Melanoma; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Skin Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Wnt1 is anti-lymphangiogenic in a melanoma mouse model.
Topics: Animals; Cyclosporine; Disease Models, Animal; Female; Humans; Lymphangiogenesis; Lymphatic Metastasis; Melanoma; Mice; Mice, Inbred C57BL; Mice, SCID; Skin Neoplasms; Tumor Cells, Cultured; Vascular Endothelial Growth Factor C; Wnt Signaling Pathway; Wnt1 Protein | 2012 |
NFATc2 is a potential therapeutic target in human melanoma.
Topics: Apoptosis; Calcineurin; Caspase 2; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Cysteine Endopeptidases; Down-Regulation; Enzyme Inhibitors; Humans; Inhibitor of Apoptosis Proteins; MAP Kinase Signaling System; Melanoma; NFATC Transcription Factors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2012 |
Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCs.
Topics: Animals; Carcinoma, Squamous Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Targeted Therapy; Organ Transplantation; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Skin Neoplasms | 2012 |
Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.
Topics: Animals; Cyclophilin A; Cyclosporine; DNA Damage; DNA-Binding Proteins; Humans; Immunosuppressive Agents; Keratinocytes; Mice; Mice, Nude; Organ Transplantation; Skin Neoplasms; Transcription, Genetic; Ultraviolet Rays | 2012 |
Conversion from calcineurin inhibitors to everolimus with low-dose cyclosporine in renal transplant recipients with squamous cell carcinoma of the skin.
Topics: Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Humans; Kidney Transplantation; Sirolimus; Skin Neoplasms | 2012 |
Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms | 2002 |
Iatrogenesis or bad luck? relapse of an LMP1-positive follicular lymphoma after immunosuppression for hepatitis-associated aplastic anaemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Fatal Outcome; Hepatitis, Viral, Human; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunosuppression Therapy; Lymphoma, Follicular; Male; Middle Aged; Recurrence; Skin Neoplasms; Viral Matrix Proteins; Virus Activation | 2002 |
Multiple cutaneous squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and ultraviolet radiation exposure which were suppressed by acitretin.
Topics: Acitretin; Alcoholism; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Leg; Male; Middle Aged; Psoriasis; PUVA Therapy; Skin Neoplasms; Ultraviolet Rays | 2003 |
Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
Topics: Biomarkers, Tumor; Cyclosporine; Etretinate; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Keratolytic Agents; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Middle Aged; Psoriasis; Risk Factors; Skin Neoplasms | 2003 |
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, SCID; Sirolimus; Skin Neoplasms; Transplantation, Homologous | 2004 |
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies.
Topics: Chemoprevention; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Multicenter Studies as Topic; Neoplasms; Neoplasms, Second Primary; Retrospective Studies; Sirolimus; Skin Neoplasms | 2004 |
Posttransplant primary cutaneous Ki-1 (CD30)+/CD56+ anaplastic large cell lymphoma.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; CD4-Positive T-Lymphocytes; CD56 Antigen; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Head and Neck Neoplasms; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; Scalp; Skin Neoplasms; Vincristine | 2004 |
EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report.
Topics: Aged; Antigens, CD; Antineoplastic Agents; Cyclosporine; Heart Transplantation; Herpesvirus 4, Human; HIV Seropositivity; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Postoperative Complications; RNA, Viral; Skin Neoplasms; Treatment Outcome | 2004 |
Large cutaneous rabbit papillomas that persist during cyclosporin A treatment can regress spontaneously after cessation of immunosuppression.
Topics: Amino Acid Sequence; Animals; Animals, Inbred Strains; Animals, Outbred Strains; Body Weight; CD4-CD8 Ratio; Cottontail rabbit papillomavirus; Cyclosporine; Disease Models, Animal; Immunocompromised Host; Immunosuppressive Agents; Molecular Sequence Data; Mutation; Neoplasm Regression, Spontaneous; Oncogene Proteins, Viral; Papilloma; Plasmids; Rabbits; Skin Neoplasms; Time Factors | 2005 |
Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice.
Topics: Animals; Carcinoma, Basal Cell; Cyclosporine; Disease Models, Animal; Glucocorticoids; Graft Rejection; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; Patched Receptors; Patched-1 Receptor; Prednisolone; Proteins; Receptors, Cell Surface; Skin Neoplasms | 2005 |
Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma.
Topics: Animals; Body Weight; Cell Line, Tumor; Choroid Neoplasms; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Neoplasms; Male; Melanocytes; Melanoma, Experimental; Penicillin G; Rabbits; Skin Neoplasms; Survival Rate | 2005 |
Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine.
Topics: Anemia; Animals; Carcinoma, Squamous Cell; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Hamartoma; Immunocompromised Host; Papillomavirus Infections; Prednisone; Skin Neoplasms | 2005 |
Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation.
Topics: Active Transport, Cell Nucleus; Apoptosis; Calcineurin Inhibitors; Cell Nucleus; Cyclosporine; DNA; DNA Damage; DNA Repair; Enzyme Inhibitors; Humans; Keratinocytes; NFATC Transcription Factors; Pyrimidine Dimers; Skin Neoplasms; Tacrolimus; Ultraviolet Rays | 2005 |
Skin cancer in renal allograft recipients--experience in different ethnic groups residing in the same geographical region.
Topics: Adult; Azathioprine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms; South Africa; Sunlight; White People | 2005 |
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors | 2005 |
Multiple haemangiomas in a psoriatic arthritis patient treated with cyclosporine.
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Forearm; Hemangioma; Humans; Male; Skin Neoplasms; Thigh | 2006 |
Regression of post-transplant Kaposi's sarcoma using sirolimus.
Topics: Cyclosporine; Female; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms; Treatment Outcome | 2006 |
Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
Topics: Blood Pressure; Calcineurin Inhibitors; Creatinine; Cyclosporine; Drug Therapy, Combination; Everolimus; Humans; Hypertension; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Postoperative Complications; Prednisolone; Sirolimus; Skin Neoplasms; Treatment Outcome; Withholding Treatment | 2006 |
Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms | 2006 |
Cutaneous Kaposi sarcoma which developed in a patient with aplastic anaemia using immunosuppressive therapy--description of the first adult case.
Topics: Anemia, Aplastic; Antineoplastic Agents, Phytogenic; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Vincristine | 2007 |
Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Panniculitis; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Treatment Outcome; Vincristine | 2007 |
Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus.
Topics: Biopsy; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Regression, Spontaneous; Sirolimus; Skin Neoplasms | 2007 |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.
Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Inflammation; Mice; Mice, Hairless; Mycophenolic Acid; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Sirolimus; Skin Neoplasms; Tacrolimus; Ultraviolet Rays | 2007 |
Long-term follow-up of cancer risk in patients treated with short-term cyclosporine.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lymphoma; Male; Middle Aged; Risk Factors; Skin Diseases; Skin Neoplasms | 2008 |
Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion.
Topics: Animals; Bongkrekic Acid; Cell Line; Cyclosporine; Membrane Potentials; Mice; Mice, Inbred DBA; Mitochondria; Protein Transport; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53 | 2008 |
Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Betamethasone Valerate; Cyclosporine; Humans; Immunocompromised Host; Kidney Diseases; Kidney Transplantation; Lung Transplantation; Male; Mechlorethamine; Mycosis Fungoides; Remission Induction; Skin; Skin Neoplasms | 2008 |
Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.
Topics: Animals; Antineoplastic Agents; Cell Count; Cyclosporine; Disease Progression; Female; Immunosuppressive Agents; Incidence; Lymph Nodes; Mast Cells; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neutrophils; Sirolimus; Skin; Skin Neoplasms; Transforming Growth Factor beta1; Tumor Burden; Ultraviolet Rays | 2008 |
Effects of oral administration of ciclosporin A on skin carcinogenesis: a study using the two-stage carcinogenesis protocol in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Carcinogens; Cyclosporine; Dose-Response Relationship, Drug; Female; Immunosuppressive Agents; Mice; Mice, Hairless; Neoplasm Staging; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2008 |
[Multiple cutaneous neoplasms in cyclosporine therapy after kidney transplantation].
Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysplastic Nevus Syndrome; Follow-Up Studies; Humans; Immune Tolerance; Kidney Transplantation; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Precancerous Conditions; Skin Neoplasms | 1995 |
Risk of neoplasia in renal transplant patients.
Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Data Collection; Databases, Factual; England; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Analysis | 1995 |
Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukemia; Lymphoma; Male; Melanoma; Neoplasms; Risk Factors; Skin Neoplasms; Time Factors | 1995 |
Aggressive squamous cell carcinomas in organ transplant recipients.
Topics: Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retinoids; Retrospective Studies; Risk Factors; Skin Neoplasms | 1995 |
Kaposi's sarcoma in renal transplant recipients: a case report.
Topics: Azathioprine; Cyclosporine; Female; Humans; Kidney Transplantation; Middle Aged; Palatal Neoplasms; Prednisone; Sarcoma, Kaposi; Skin Neoplasms | 1994 |
Transmission of Kaposi's sarcoma by solid organ donation.
Topics: Adult; Azathioprine; Cyclosporine; Disease Transmission, Infectious; Fatal Outcome; Female; Follow-Up Studies; Humans; Kidney Transplantation; Liver Neoplasms; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Sarcoma, Kaposi; Skin Neoplasms; Tissue Donors | 1994 |
Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients.
Topics: Adult; Carcinoma; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Neoplasms; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Time Factors | 1995 |
Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Topics: Adenosine Triphosphatases; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Animals; Antigens, CD; Azathioprine; Carcinoma, Basal Cell; Cell Adhesion Molecules; Cell Line, Transformed; Cell Movement; Cyclosporine; Female; HLA-DR Antigens; Humans; Immune Tolerance; Intercellular Adhesion Molecule-1; Langerhans Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Nude; Middle Aged; Monitoring, Immunologic; Neoplasm Transplantation; Neoplasms, Radiation-Induced; Prednisolone; PUVA Therapy; Skin; Skin Neoplasms; T-Lymphocytes; Ultraviolet Rays | 1993 |
Skin disease in immunosuppressed patients in relation to epidermal Langerhans' cells.
Topics: Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Langerhans Cells; Male; Middle Aged; Prednisolone; Prevalence; Skin Diseases; Skin Neoplasms; Time Factors; Warts | 1993 |
De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Life Tables; Lymphoma; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Risk Factors; Skin Neoplasms; Time Factors | 1994 |
Bowenoid change in association with graft-versus-host disease: a cyclosporine toxicity?
Topics: Bone Marrow Transplantation; Bowen's Disease; Cyclosporine; Graft vs Host Disease; Humans; Male; Middle Aged; Skin Neoplasms | 1994 |
Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases.
Topics: Adolescent; Adult; Azathioprine; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Immune Tolerance; Immunosuppression Therapy; Incidence; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Care; Prevalence; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Time Factors; Transplantation Immunology | 1994 |
Cancer development in pediatric primary renal allograft recipients.
Topics: Adolescent; Adult; Age Factors; Child; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma; Male; Minnesota; Neoplasms; Skin Neoplasms | 1994 |
Systemic immunosuppression and oral malignancy: a report of a case and review of the literature.
Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunocompromised Host; Immunologic Surveillance; Immunosuppression Therapy; Kidney Transplantation; Lip Neoplasms; Male; Prednisolone; Skin Neoplasms | 1993 |
Kaposi's sarcoma in kidney transplant recipients.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Incidence; Italy; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms | 1993 |
Cutaneous malignancy related to cyclosporin A therapy.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Humans; Male; Methotrexate; Psoriasis; Skin Neoplasms | 1993 |
De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.
Topics: Australia; Azathioprine; Cadaver; Cyclosporine; Female; Humans; Kidney Transplantation; Morbidity; Neoplasms; New Zealand; Prednisone; Probability; Registries; Risk Factors; Skin Neoplasms; Time Factors; Tissue Donors; Treatment Failure | 1993 |
Papilloma development in cyclosporine-treated patients.
Topics: Adult; Cyclosporine; Humans; Hyperplasia; Male; Papilloma; Skin; Skin Neoplasms | 1993 |
Cancers in cyclosporine-treated vs azathioprine-treated patients.
Topics: Adult; Azathioprine; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Neoplasms; Kidney Transplantation; Lip Neoplasms; Lymphoma; Neoplasms; Sarcoma, Kaposi; Skin Neoplasms; Transplantation Immunology; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1996 |
Kaposi sarcoma in a paediatric renal transplant recipient.
Topics: Adolescent; Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine | 1996 |
Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon.
Topics: Adult; Cyclosporine; Cytomegalovirus Infections; Hepatitis B; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Male; Postoperative Complications; Sarcoma, Kaposi; Skin Neoplasms | 1996 |
Effect of extended sleep deprivation on tumor growth in rats.
Topics: Animals; Body Weight; Carcinoma; Cell Division; Cyclosporine; Eating; Male; Neoplasm Transplantation; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Skin Neoplasms; Sleep Deprivation | 1996 |
Excess benign melanocytic naevi in renal transplant recipients.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Back; Buttocks; Case-Control Studies; Cyclosporine; Follow-Up Studies; Foot Diseases; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Melanoma; Middle Aged; Nevus, Pigmented; Prednisone; Prevalence; Risk Factors; Skin Neoplasms; Time Factors; Transplantation, Homologous | 1997 |
Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients.
Topics: Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Prednisolone; Skin Neoplasms | 1997 |
Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
Topics: Acitretin; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Neoplasms, Multiple Primary; Psoriasis; PUVA Therapy; Skin Neoplasms | 1997 |
Kaposi's sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Female; Follow-Up Studies; HIV Seronegativity; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Neoplasm Staging; Prednisone; Remission Induction; Rome; Sarcoma, Kaposi; Skin Neoplasms; Virus Diseases | 1997 |
Vinorelbine therapy for Kaposi's sarcoma in a kidney transplant patient.
Topics: Antineoplastic Agents, Phytogenic; Azathioprine; Cyclosporine; Disease Progression; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphatic Metastasis; Male; Middle Aged; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine; Vinorelbine | 1997 |
[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid].
Topics: Aged; Cell Transformation, Neoplastic; Cyclosporine; Humans; Immunosuppressive Agents; Male; Photosensitivity Disorders; Risk Factors; Sarcoma, Kaposi; Skin; Skin Neoplasms | 1997 |
Kaposi's sarcoma as manifestation of immunosuppression in organ transplant recipients.
Topics: Anti-Inflammatory Agents; Azathioprine; Combined Modality Therapy; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms | 1997 |
Study of malignancy among Egyptian kidney transplant recipients.
Topics: Azathioprine; Cyclosporine; Egypt; Female; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms | 1997 |
Merkel cell carcinoma arising after therapeutic immunosuppression.
Topics: Aged; Azathioprine; Carcinoma, Merkel Cell; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Skin Neoplasms | 1997 |
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents | 1998 |
Recurrent Kaposi's sarcoma in a renal transplant recipient maintained on minimum doses of immunosuppression.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Recurrence; Sarcoma, Kaposi; Skin Neoplasms | 1998 |
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?
Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Glucocorticoids; Head and Neck Neoplasms; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Myocardial Ischemia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Opportunistic Infections; Prednisolone; Skin Neoplasms | 1998 |
Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in renal transplant patient.
Topics: Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muscle, Skeletal; Scalp; Skin Neoplasms; Skin Transplantation; Transplantation, Autologous; Transplantation, Homologous | 1998 |
Eruptive angiomas after treatment with cyclosporine in a patient with psoriasis.
Topics: Adult; Cyclosporine; Dermatologic Agents; Hemangioma; Humans; Male; Psoriasis; Skin Neoplasms | 1998 |
Kaposi's sarcoma after renal transplantation: treatment with liposomal doxorubicin.
Topics: Adult; Antineoplastic Agents; Cyclosporine; Doxorubicin; Drug Carriers; Humans; Immunosuppressive Agents; Kidney Transplantation; Liposomes; Male; Sarcoma, Kaposi; Skin Neoplasms; Tacrolimus | 1999 |
A nonhealing ulcer diagnosed as extramedullary plasmocytoma of the limb eight years after cardiac transplantation.
Topics: Cyclosporine; Graft Rejection; Heart Transplantation; Hematopoiesis, Extramedullary; Humans; Immunosuppressive Agents; Leg Ulcer; Male; Middle Aged; Plasmacytoma; Skin Neoplasms | 1999 |
Induction of mitochondrial permeability transition and cytochrome C release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Caspase Inhibitors; Caspases; Cyclosporine; Cytochrome c Group; Cytosol; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fluorescence; HL-60 Cells; Humans; Intracellular Membranes; Melanoma; Mitochondria; Mitochondria, Liver; Neoplasm Proteins; Oligopeptides; Permeability; Photochemistry; Pyrimidinones; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Signal Transduction; Skin Neoplasms; Staurosporine; Tumor Cells, Cultured | 2000 |
Iatrogenic Kaposi's sarcoma: HHV8 positivity persists but the tumors regress almost completely without immunosuppressive therapy.
Topics: Azathioprine; Cyclosporine; Herpesvirus 8, Human; Humans; Iatrogenic Disease; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasm Regression, Spontaneous; Prednisolone; Sarcoma, Kaposi; Skin Neoplasms | 2000 |
Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead.
Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Remission, Spontaneous; Retreatment; Sarcoma, Kaposi; Skin Neoplasms | 2000 |
Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy.
Topics: Age Distribution; Azathioprine; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Keratosis; Male; Middle Aged; Prednisone; Proportional Hazards Models; Risk Factors; Skin Neoplasms; Skin Pigmentation; Sunlight | 2000 |
Cyclosporine in the treatment of psoriasis.
Topics: Clinical Trials as Topic; Creatinine; Cyclosporine; Dermatologic Agents; Drug Interactions; Follow-Up Studies; Humans; Kidney; Patient Selection; Psoriasis; Risk Factors; Skin Neoplasms; Time Factors | 2000 |
Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
Topics: Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Prednisolone; Proportional Hazards Models; Retrospective Studies; Risk; Skin Neoplasms | 2000 |
Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis.
Topics: Anticarcinogenic Agents; Apoptosis; Ascorbic Acid; Carcinoma, Squamous Cell; Cell Division; Cyclosporine; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fenretinide; Fluoresceins; Fluorescent Dyes; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Oxidation-Reduction; Permeability; Reactive Oxygen Species; Rhodamine 123; Skin Neoplasms; Tumor Cells, Cultured | 2000 |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease.
Topics: Adult; Atrophy; Cutis Laxa; Cyclosporine; DNA; Elastic Tissue; Female; Fluorescein-5-isothiocyanate; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunohistochemistry; In Situ Hybridization; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Polymerase Chain Reaction; RNA, Viral; Skin Neoplasms; Tacrolimus | 2001 |
Kidney transplantation and Kaposi's sarcoma: review of 2050 recipients.
Topics: Cyclosporine; Cytomegalovirus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Iran; Kidney Transplantation; Male; Postoperative Complications; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms; Time Factors | 2001 |
Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
Topics: Carcinoma, Squamous Cell; Cross-Over Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Prospective Studies; Psoriasis; PUVA Therapy; Risk Factors; Skin Neoplasms | 2001 |
Induction of apoptosis in AK-5 tumor cells by a serum factor from tumor rejecting animals: cytochrome c release independent of Bcl-2 and caspases.
Topics: Animals; Apoptosis; Biological Factors; Biological Transport; Caspases; Cyclosporine; Cytochrome c Group; Histiocytoma, Benign Fibrous; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasm Transplantation; Permeability; Proto-Oncogene Proteins c-bcl-2; Rats; Skin Neoplasms; Transfection; Tumor Cells, Cultured | 2001 |
Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment.
Topics: Adult; Biopsy; Cell Transformation, Neoplastic; Cyclosporine; Dermatitis, Atopic; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoma, Large-Cell, Anaplastic; Male; Mycosis Fungoides; Polymerase Chain Reaction; Psoriasis; Skin Neoplasms; Staphylococcal Skin Infections | 2001 |
Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine.
Topics: Cyclosporine; Diagnosis, Differential; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Mycosis Fungoides; Psoriasis; Risk Assessment; Severity of Illness Index; Skin Neoplasms | 2002 |
Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine.
Topics: Carcinoma, Merkel Cell; Cyclosporine; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Skin Neoplasms | 2002 |
Cancer after transplantation in Catalonia.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Neoplasms; Prednisone; Retrospective Studies; Skin Neoplasms; Spain; Transplantation, Homologous | 1992 |
[Cyclosporine in dermatology].
Topics: Cyclosporine; Humans; Skin Neoplasms | 1992 |
Sebaceous hyperplasia and basal cell carcinoma in a renal transplant patient receiving cyclosporine.
Topics: Carcinoma, Basal Cell; Cyclosporine; Humans; Hyperplasia; Kidney Transplantation; Male; Middle Aged; Sebaceous Glands; Skin Neoplasms | 1992 |